Core Laboratories Inc. /DE/·4

May 5, 2:53 PM ET

Tattoli Mark Damian 4

4 · Core Laboratories Inc. /DE/ · Filed May 5, 2025

Insider Transaction Report

Form 4
Period: 2025-05-01
Tattoli Mark Damian
SVP, Gen Counsel & Secretary
Transactions
  • Tax Payment

    Common Stock

    2025-05-01$11.68/sh99$1,15616,143.621 total
  • Exercise/Conversion

    Common Stock

    2025-05-01+25016,242.621 total
  • Tax Payment

    Common Stock

    2025-05-01$11.68/sh79$92315,992.621 total
  • Exercise/Conversion

    Common Stock

    2025-05-01+20016,071.621 total
  • Exercise/Conversion

    Restricted Shares

    2025-05-012502,400 total
    Common Stock (250 underlying)
  • Exercise/Conversion

    Restricted Shares

    2025-05-012002,650 total
    Common Stock (200 underlying)
Holdings
  • Common Stock

    (indirect: Custodial account)
    20
  • Common Stock

    (indirect: 401 (k) Plan)
    1,694.842
Footnotes (2)
  • [F1]The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date.
  • [F2]Multiple restricted share grants are included in this total.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4